Stanford scientists produced a common cancer drug – previously only available from an endangered plant – in a common laboratory plant. This work could lead to a more stable supply of the drug and allow scientists to manipulate that drug to make it even safer and more effective.

A miniature device that combines optogenetics – using light to control the activity of the brain – with a newly developed technique for wirelessly powering implanted devices is the first fully internal method of delivering optogenetics. The blue glowing device the size of a peppercorn can activate neurons of the brain, spinal cord or limbs in mice and is powered wirelessly using the mouse's own body to transfer energy. Represents collaboration PI and Post Docs, multi-discipline, Known4 Labs.

A new microscope could provide unique insights into treating muscular degenerative diseases. Stanford News reports on a collaboration of scientists in bioengineering, biology and applied physics which has developed a microscope that can visualize and measure the force-generating contractions of these patients' individual motor units.

Drawing faculty and students from across all seven schools of Stanford University, Bio-X pursues breakthrough discoveries advancing our understanding of the human body and educates the next generation of visionary scientific leaders.